Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

SEC filing history

Showing 1-25 of 176 matching filings.

Per page
25
Current page
1
8-K File 001-36332

CURRENT REPORT

Filing date
17 Jul 2025
Reporting date
17 Jul 2025
Next action
Verify source filing
8-K File 001-36332

CURRENT REPORT

Filing date
26 Jun 2025
Reporting date
26 Jun 2025
Next action
Verify source filing
8-K File 001-36332

CURRENT REPORT

Filing date
17 Apr 2025
Reporting date
17 Apr 2025
Next action
Verify source filing
8-K File 001-36332

CURRENT REPORT

Filing date
18 Nov 2024
Reporting date
15 Nov 2024
Next action
Verify source filing
8-K File 001-36332

CURRENT REPORT

Filing date
03 Oct 2024
Reporting date
03 Oct 2024
Next action
Verify source filing
8-K File 001-36332

CURRENT REPORT

Filing date
08 Aug 2024
Reporting date
08 Aug 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .